Anti-HCV neutralizing monoclonal antibodies (Progenics Pharmaceuticals)
N/A
Report date: 2023/01/14 14:15:25
Base Information
Drug NameAnti-HCV neutralizing monoclonal antibodies (Progenics Pharmaceuticals)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesProgenics Pharmaceuticals Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesProgenics Pharmaceuticals Inc
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A